Neal James R
SEC CIK 1600865 · EDGAR
BoughtSold
Most active insiders at PCSA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Ng George K | CEO, Dir | $55.0K | — |
| 2 | SKIBSTED RUSSELL | CFO | $41.7K | — |
| 3 | Guy Wendy | Chief Administrative Off | $32.9K | — |
| 4 | Young David | Pres. Research, Development, Dir | $32.4K | — |
| 5 | Lin Patrick | Chief Business - Strategy Off | $28.5K | — |
| 6 | Bigora Sian | Chief Development Off | $21.4K | — |
| 7 | Baluch Khoso | Dir | $5,752 | — |
| 8 | Pannu Geraldine | Dir | $5,253 | — |
| 9 | Neal James R | Dir | $2,000 | — |
| 10 | Yorke Justin W | Dir | — | — |
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-30 16:47 | 2026-06-26 | PCSA | Processa Pharmaceuticals, Inc. | Neal James R | Dir | M - OptEx | — | +203 | 1,021 | +25% | — |
| 2026-04-02 17:12 | 2026-03-31 | PCSA | Processa Pharmaceuticals, Inc. | Neal James R | Dir | P - Purchase | $2.54 | +789 | 818 | +2,721% | +$2,000 | |
| D | 2025-03-10 | 2025-03-06 | AKTX | Akari Therapeutics Plc | Neal James R | Dir | A - Grant | $1.12 | +4,464 | 36.3K | +14% | +$5,000 |
| 2025-01-10 | 2025-01-09 | AKTX | Akari Therapeutics Plc | Neal James R | Dir | A - Grant | $0.00 | +8.00M | 32.22M | +33% | $0 | |
| 2024-12-26 | 2024-12-23 | AKTX | Akari Therapeutics Plc | Neal James R | Dir | A - Grant | $0.00 | +2.00M | 24.22M | +9% | $0 | |
| DM | 2024-02-13 | 2024-02-09 | PALI | PALISADE BIO, INC. | Neal James R | Dir | M - OptEx | $0.00 | +10.9K | 5,100 | New | $0 |
| D | 2023-07-24 | 2023-06-27 | PCSA | Processa Pharmaceuticals, Inc. | Neal James R | Dir | M - OptEx | — | +14.4K | 14.4K | New | — |
Purchase Sale Sale after option exercise All abbreviations